Skip to main content

Advertisement

Log in

Myeloperoxidase cytochemical negativity: an unexpected but intrinsic property of blasts of all phases of chronic myeloid leukemia

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Myeloperoxidase (MPO) cytochemical activity, recognized as a very important hallmark of myeloblasts, is generally negative in chronic myeloid leukemia (CML) blast crisis (BC). Because this finding is unexpected, being not in keeping with the myeloproliferative nature of CML, we tried to ascertain if MPO cytochemical negativity could be an intrinsic property of blasts of CML and hence present in the preblastic phases as well. Myeloperoxidase cytochemistry of peripheral blood blasts in 161 cases of CML, including 103 in chronic phase (CP) and 29 each in accelerated phase (AP) and BC, was assessed and compared with that of 30 cases of acute myeloid leukemia, AML-M2. Blasts of 97 (94.2%) of 103 cases of CP, 28 (96.6%) of 29 cases of AP, and 22 (75.9%) of 29 cases of BC were negative for MPO (<3% MPO-positive blasts). Compared with the strong MPO positivity, both in terms of intensity and proportion, in the AML-M2 cases, the positivity in the CML cases was generally weak and was seen in a small number of blasts (5–15%), except in one case of BC with 20% positive blasts. Absence or, at times, weak MPO cytochemical activity is an intrinsic property of blasts of all phases of CML, and use of the term myeloblast in CML should be understood to refer to a cell with this property. This also explains why MPO cytochemistry, despite its high reputation as a myeloid-lineage marker, generally does not help in CML BC. CML BC should therefore be considered as a possible diagnosis along with acute lymphoblastic leukemia, AML-M0, AML-M7, etc., in the setting of MPO-negative blasts. Similarity between MPO expression pattern in CML, i.e., negative in blasts and positive in the more mature cells, and that during maturation of normal myeloid series of cells shows the deranged myelopoiesis of CML to be undisturbed at least with respect to MPO expression. There is need for a more comprehensive study of blasts of preblastic phases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Childs CG, Stass SA (1987) Introduction. Characterization and diagnosis of the acute leukemias. In: Stass SA (ed) The acute leukemias. Biologic, diagnostic and therapeutic determinants. Marcel Dekker, New York, pp 1–26

    Google Scholar 

  2. Peffault de Latour RP, Legrand O, Moreau D, Perrot JY, Blanc CM, Chaoui D, Casadevall N, Marie JP (2003) Comparison of flow cytometry and enzyme cytochemistry for the detection of myeloperoxidase in acute myeloid leukaemia: interests of a new positivity threshold. Br J Haematol 122:211–216

    Article  PubMed  Google Scholar 

  3. Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A, van’t Veer MB (1995) Proposals for the immunological classification of acute leukemias. European group for the immunological characterization of leukemias (EGIL). Leukemia 9:1783–1786

    PubMed  CAS  Google Scholar 

  4. Vardiman JW, Pierre R, Thiele J, Imbert M, Brunning RD, Flandrin G (2001) Chronic myelogenous leukemia. In: Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) Pathology and genetics of tumours of haematopoietic and lymphoid tissues. IARC, Lyon, pp 20–26

    Google Scholar 

  5. Anastasi J, Vardiman JW (2000) Chronic myelogenous leukemia and the chronic myeloproliferative diseases. In: Knowles DM (ed) Neoplastic hematopathology. Lippincott Williams and Wilkins, Philadelphia, pp 1745–1790

    Google Scholar 

  6. Peterson LC, Bloomfield CD, Brunning RD (1976) Blast crisis as an initial or terminal manifestation of chronic myeloid leukemia. A study of 28 patients. Am J Med 60:209–220

    Article  PubMed  CAS  Google Scholar 

  7. Catovsky D, O’Brien M, Cherchi M, Benavides I (1978) Ultrastructural, cytochemical and surface marker analysis of cells during blast crisis of chronic granulocytic leukaemia. Boll Ist Sieroter Milan 57:344–354

    PubMed  CAS  Google Scholar 

  8. Vardiman JW, Coelho A, Golomb HM, Rowley J (1983) Morphologic and cytochemical observations on the overt leukemic phase of therapy-related leukemia. Am J Clin Pathol 79:525–530

    PubMed  CAS  Google Scholar 

  9. Saikia T, Advani S, Dasgupta A, Ramakrishnan G, Nair C, Gladstone B, Kumar MS, Badrinath Y, Dhond S (1988) Characterization of blast cells during blastic phase of chronic myeloid leukemia by immunophenotyping—experience in 60 patients. Leuk Res 12:499–506

    Article  PubMed  CAS  Google Scholar 

  10. Karnik MP, Nair CN, Zingde SM, Gothoskar BP, Zachariah L, Barbhaya S, Advani SH (1994) Use of polyclonal anti-myeloperoxidase antibody in myeloid lineage determination. Indian J Med Res 100:272–276

    PubMed  CAS  Google Scholar 

  11. Hughes TP, Goldman JM (1990) Chronic myeloid leukemia. In: Hoffman R, Benz EJ Jr, Shattil SJ, Furie B, Cohen HJ, Hughes TP, Goldman JM (eds) Hematology: basic principles and practice. Churchill Livingstone, New York, pp 854

    Google Scholar 

  12. International Committee for Standardization in Haematology (ICSH) (1985) Recommended methods for cytological procedures in haematology. Clin Lab Haematol 7:55–74

    Google Scholar 

  13. Rosenthal S, Canellos GP, DeVita VT, Gralnick HR (1977) Characteristics of blast crisis in chronic granulocytic leukemia. Blood 49:705–714

    PubMed  CAS  Google Scholar 

  14. Farber S, Diamond LK, Mercer RD, Sylvester RF Jr, Wolff JA (1948) Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-gultamic acid (aminopterin). N Engl J Med 238:787–793

    Article  CAS  PubMed  Google Scholar 

  15. Mauer AM (1990) Clinical features of human leukemia. In: Mauer AM (ed) The biology of human leukemia. The Johns Hopkins University Press, Baltimore, pp 1–22

    Google Scholar 

  16. Bennett JM (1990) The diagnosis of acute and chronic leukemias: morphologic consideration. In: Mauer AM (ed) The biology of human leukemia. The Johns Hopkins University Press, Baltimore, pp 23–43

    Google Scholar 

  17. Rabinowitz I, Larson RS (2004) Chronic myeloid leukemia. In: Greer JP, Foerster J, Lukens JN, Rodgers GM, Paraskevas F, Glader B (eds) Wintrobe’s clinical hematology, Lippincott Williams and Wilkins, Philadelphia, pp 2235–2258

    Google Scholar 

  18. Brunning RD, McKenna RW (1994) Tumors of the bone marrow. Armed Forces Institute of Pathology, Washington, DC, pp 195–254

    Google Scholar 

  19. Bettelheim P, Lutz D, Majdic O, Paietta E, Haas O, Linkesch W, Neumann E, Lechner K, Knapp W (1985) Cell lineage heterogeneity in blast crisis of chronic myeloid leukaemia. Br J Haematol 59:395–409

    PubMed  CAS  Google Scholar 

  20. Polli N, O’Brien M, Tavares de Castro J, Matutes E, San Miguel JF, Catovsky D (1985) Characterization of blast cells in chronic granulocytic leukaemia in transformation, acute myelofibrosis and undifferentiated leukaemia. I. Ultrastructural morphology and cytochemistry. Br J Haematol 59:277–296

    PubMed  CAS  Google Scholar 

  21. San Miguel JF, Tavares de Castro J, Matutes E, Rodriguez B, Polli N, Zola H, McMichael AJ, Bollum FJ, Thompson DS, Goldman JM, Catovsky D (1985) Characterization of blast cells in chronic granulocytic leukaemia in transformation, acute myelofibrosis and undifferentiated leukaemia. II. Studies with monoclonal antibodies and terminal transferase. Br J Haematol 59:297–309

    PubMed  Google Scholar 

  22. Armitage FL (1939) A modified peroxidase stain for blood and bone marrow films. Pathol Bacteriol 49:579–581

    Article  Google Scholar 

  23. Brederoo P, van der Meulen J, Daems WT (1986) Ultrastructural localization of peroxidase activity in developing neutrophils, granuloyctes from human bone marrow. Histochemistry 84:445–453

    Article  PubMed  CAS  Google Scholar 

  24. Marmont AM, Damasio E, Zucker-Frunklin D (1988) Neutrophils. In: Zucker-Franklin D, Greaves MF, Grossi CE, Marmont AM (eds) Atlas of blood cells. Function and pathology. Lea & Febiger, Philadelphia, pp 159–161

    Google Scholar 

  25. Bainton DF, Ullyot JL, Farquhar MG (1971) The development of neutrophilic polymorphonuclear leukocytes in human bone marrow. Origin and content of azurophil and specific granules. J Exp Med 134:907–934

    Article  PubMed  CAS  Google Scholar 

  26. Terstappen LWMM, Safford M, Loken MR (1990) Flow cytometric analysis of human bone marrow III. Neutrophil maturation. Leukemia 4:657–663

    PubMed  CAS  Google Scholar 

  27. Koeffler HP, Ranyard J, Pertcheck (1985) Myeloperoxidase: its structure and expression during myeloid differentiation. Blood 65:484–491

    PubMed  CAS  Google Scholar 

  28. Tobler A, Miller CW, Johnson KR, Selsted ME, Rovera G, Koeffler HP (1988) Regulation of gene expression of myeloperoxidase during myeloid differentiation. J Cell Physiol 136:215–225

    Article  PubMed  CAS  Google Scholar 

  29. Lubbert M, Herrmann F, Koeffler HP (1991) Expression and regulation of myeloid—specific genes in normal and leukemic myeloid cells. Blood 77:909–924

    PubMed  CAS  Google Scholar 

  30. Strobl H, Takimoto M, Majdic O, Fritsch G, Scheinecker C, Hocker P, Knapp W (1993) Myeloperoxidase expression in CD34+ normal human hematopoietic cells. Blood 82:2069–2078

    PubMed  CAS  Google Scholar 

  31. Scholz W, Platzer, Schumich A, Hocher B, Fritsch G, Knapp W, Strobl H (2004) Initial human myeloid/dendritic cell progenitors identified by absence of myeloperoxidase protein expression. Exp Hematol 32:270–276

    Article  PubMed  CAS  Google Scholar 

  32. Lichtman MA (1995) Chronic myelogenous leukemia and related disorders. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ (eds) Hematology. McGraw-Hill, New York, pp 298

    Google Scholar 

  33. Vainchenker W, Villeval JL, Tabilio A, Matamis H, Karianakis G, Guichard J, Henri A, Vernant JP, Rochant H, Breton-Gorius J (1988) Immunophenotype of leukemic blasts with small peroxidase-positive granules detected by electron microscopy. Leukemia 2:274–281

    PubMed  CAS  Google Scholar 

  34. Koeffler HP, Golde DW (1978) Acute myelogenous leukemia: a human cell line responsive to colony-stimulating activity. Science 200:1153–1154

    Article  PubMed  CAS  Google Scholar 

  35. Koeffler HP, Billings R, Lusis AJ, Sparkes R, Golde DW (1980) An undifferentiated variant derived from the human acute myelogenous leukemia cell line (KG-1). Blood 56:265–273

    PubMed  CAS  Google Scholar 

  36. Bain BJ (1999) Leukemia diagnosis, 2nd edn. Blackwell Science Ltd, Oxford

    Google Scholar 

  37. Martin-Henao GA, Quiroga R, Sureda A, Garcia J (1999) CD7 expression on CD34+ cells from chronic myeloid leukaemia in chronic phase. Am J Hematol 61:178–186

    Article  PubMed  CAS  Google Scholar 

  38. Schmetzer HM, Gehartz HH (1997) Immunological classification of chronic myeloid leukemia distinguishes chronic phase, imminent blastic transformation and acute lymphoblastic leukemia. Exp Hematol 25:502–508

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rajive Kumar.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Anand, M., Ghara, N., Kumar, R. et al. Myeloperoxidase cytochemical negativity: an unexpected but intrinsic property of blasts of all phases of chronic myeloid leukemia. Ann Hematol 84, 767–770 (2005). https://doi.org/10.1007/s00277-005-1056-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-005-1056-y

Keywords

Navigation